skip links

Media Inquiries

Beth Calitri

Corporate Communications, Media Relations

978.417.2031

[email protected]
Sort by Year
July 10, 2012

Ironwood Pharmaceuticals to Host Second Quarter 2012 Investor Update Call

May 29, 2012

Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences

May 14, 2012

Ironwood and Forest to Present 17 Linaclotide-Related Abstracts at Digestive Disease Week® 2012

May 8, 2012

Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 Health Care Conference

May 1, 2012

Ironwood Pharmaceuticals Provides First Quarter 2012 Investor Update

April 24, 2012

Ironwood Pharmaceuticals to Host First Quarter 2012 Investor Update Call

April 23, 2012

Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012

February 28, 2012

Ironwood Pharmaceuticals Provides Fourth Quarter 2011 Investor Update

February 27, 2012

Ironwood Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference

February 21, 2012

Ironwood Pharmaceuticals to Host Fourth Quarter 2011 Investor Update Call

February 13, 2012

Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

February 9, 2012

Ironwood Pharmaceuticals Prices Public Offering of Common Stock

February 8, 2012

Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock

February 8, 2012

Ironwood Announces FDA Advisory Committee Meeting Will Not Be Scheduled in Connection with New Drug Application for Linaclotide

January 4, 2012

Ironwood Pharmaceuticals and Bionomics Announce Collaboration, Research, and License Agreement